Skip to main content
. 2024 Jul 8;2024:7624416. doi: 10.1155/2024/7624416

Table 4.

Antimicrobial susceptibility pattern of GPB isolated from bacteremia-suspected patients at the UoG-CSH.

Antibiotics S. aureus Enterococcus species CoNS S. viridans S. pneumoniae Total (%)
S R S R S R S R S R S (%) R (%)
PEN 9 76 5 19 3 10 0 1 1 4 18 (14.1) 110 (85.9)
AMP/AMX 0 1 1 3 2 0 1 4 4 (33.3) 8 (66.7)
PIP/TAZ 0 1 1 4 1 (26.7) 5 (83.3)
CRX 9 17 8 9 2 5 4 4 2 3 25 (39.7) 38 (60.3)
CRO 2 2 0 3 3 0 1 1 6 (50.0) 6 (50.0)
OXA 1 0 0 1 0 1 0 1 2 1 3 (42.9) 4 (57.1)
CTX 32 28 4 5 1 1 37 (52.1) 34 (47.9)
CIP 22 6 2 1 3 4 1 1 0 1 28 (68.3) 13 (31.7)
MER 5 5 1 4 0 1 0 2 1 1 7 (35.0) 13 (65.0)
SXT 7 1 1 0 0 1 8 (80.0) 2 (20.0)
GEN 11 11 1 6 1 4 2 1 1 1 16 (41.0) 23 (59.0)
AMK 39 19 2 2 8 1 1 2 50 (67.6) 24 (32.4)
CLI 8 7 1 0 2 1 3 0 14 (63.6) 8 (36.4)
CAF 16 1 13 2 6 3 4 2 4 0 43 (84.3) 8 (15.7)
DOX 9 0 22 8 5 1 2 2 3 0 41 (78.8) 11 (11.2)
ERY 3 3 0 2 0 1 3 (33.3) 6 (66.7)
TOB 8 6 0 2 1 3 9 (45) 11 (55)
TET 5 18 5 13 0 5 2 5 2 3 14 (24.1) 44 (75.9)
Total (%) 179 (41.1) 201 (52.9) 69 (46.9) 78 (53.1) 39 (47.6) 43 (52.4) 21 (41.2) 30 (58.8) 19 (54.3) 16 (45.7) 327 (47.05) 368 (52.95)

Note. PEN: penicillin; AMP/AMX: ampicillin/amoxicillin; PIP/TAZ: piperacillin/tazobactam; CRX: cefuroxime; CRO: ceftriaxone; OXA: oxacillin; CTX: cefoxitin; CIP: ciprofloxacin; MER: meropenem; SXT: trimethoprim-sulfamethoxazole; GEN: gentamicin; AMK: amikacin; CLI: clindamycin; CAF: chloramphenicol; DOX: doxycycline; ERY: erythromycin; TOB: tobramycin; TET: tetracycline; S: sensitive; R: resistant; CoNS: coagulase-negative Staphylococcus aureus.